The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ProQR Therapeutics N.V(NASDAQ:PRQR) 
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421...
Website: http://www.proqr.com
Founded: 2012
Full Time Employees: 154
Sector: Healthcare
Industry: Biotechnology
ProQR Therapeutics N.V Days Payable Outstanding ttm (DPO)
ProQR Therapeutics N.V Days Receivable Outstanding ttm (DSO)
ProQR Therapeutics N.V Days Inventory Outstanding ttm (DIO)
ProQR Therapeutics N.V Op Cashflow Per Share ttm
ProQR Therapeutics N.V Free Cashflow Per Share ttm
ProQR Therapeutics N.V Cash Per Share ttm
ProQR Therapeutics N.V P/S ratio ttm
ProQR Therapeutics N.V (GAAP) P/E ratio ttm
ProQR Therapeutics N.V P/B ratio ttm
No extra charts and metrics for this ticker.